2836 Federal Register / Vol. 61, No. 19 / Monday, January 29, 1996 / Notices

2See Prepared Remarks of Christine A. Varney,

‘‘Responses to the Managed Care Revolution: A

Competition Policy Perspective,’’ Conference of the

National Ass’n of Retail Druggists, March 27, 1995.

lessened competition. But, in doing so, I

want to emphasize that joint ventures by

retail pharmacists can be precompetitive by

injecting new competition into the market for

pharmacy benefit management services.2 I

believe many of RxCare’s programs can be

procompetitive. The matter before the FTC

concerns only one aspect of RxCare’s

pharmacy benefit management programs—its

imposition of a most favored nations clause.

By working on an expedited basis, staff has

been able to identify this concern quickly

and, by working closely with RxCare, has

resolved it in a mutually agreeable fashion.

[FR Doc. 96–1497 Filed 1–28–96; 8:45 am]

BILLING CODE 6750–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

Product and Establishment License

Applications, Refusal to File; Meeting

of Oversight Committee; Cancellation

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug

Administration (FDA) is announcing

cancellation of the meeting for January

1996 of its standing oversight committee

(the committee) in the Center for

Biologics Evaluation and Research

(CBER) that conducts a periodic review

of CBER’s use of its refusal to file (RTF)

practices on product license

applications (PLA’s) and establishment

applications (ELA’s). The meeting is

being cancelled because there were no

RTF actions taken by CBER in the

previous quarter. CBER’s RTF oversight

committee examines all RTF decisions

which occurred during the previous

quarter to assess consistency across

CBER offices and divisions in RTF

decisions.

DATES: The meeting scheduled for

January 1996 is cancelled. The next

meeting is scheduled for April 1996.

FOR FURTHER INFORMATION CONTACT: Joy

A. Cavagnaro, Center for Biologics

Evaluation and Research (HFM–2), Food

and Drug Administration, 1401

Rockville Pike, Rockville, MD 20852–

1448, 301–827–0372.

SUPPLEMENTARY INFORMATION: In the

Federal Register of May 15, 1995 (60 FR

25920), FDA announced the

establishment of a standing oversight

committee in CBER to conduct periodic

reviews of CBER’s use of its RTF

practices on PLA’s and ELA’s. The May

15 notice stated that the committee

meetings would be held quarterly to

review all of the RTF decisions. The

January 1996 committee meeting is

being cancelled because there were no

RTF actions taken by CBER in the

previous quarter.

Dated: January 22, 1996.

William K. Hubbard,

Associate Commissioner for Policy

Coordination.

[FR Doc. 96–1513 Filed 1–26–96; 8:45 am]

BILLING CODE 4160–01–F

National Institutes of Health

‘‘Infant Sleep Position and Sudden

Infant Death Syndrome (SIDS) Risk’’

Study; Proposed Data Collection

In compliance with Section

3506(c)(2)(A) of the Paperwork

Reduction Act of 1995, the National

Institute of Child Health and Human

Development (NICHD), National

Institutes of Health (NIH) is publishing

this notice to solicit public comment on

the data collection proposed for the

study on ‘‘Infant Sleep Position and

SIDS Risk’’ for the Pregnancy and

Perinatology Program. To request copies

of the data collection plans and

instruments, call Dr. Marian Willinger,

(301) 496–5575 (not a toll-free number).

Comments are invited on: (a) whether

the proposed collection is necessary,

including whether the information has a

practical use; (b) ways to enhance the

clarity, quality, and use of the

information to be collected; (c) the

accuracy of the agency estimate of

burden of the proposed collection; and

(d) ways to minimize the collection

burden of the respondents. Written

comments are requested within 60 days

of the publication of this notice. Send

comments to Dr. Marian Willinger,

Pregnancy and Perinatology Branch,

Center for Research for Mothers and

Children (CRMC), NICHD, NIH,

Building 6100, Room 4B11H, 6100

Executive Boulevard, Bethesda, MD

20852.

Proposed Project

The Center for Research for Mothers

and Children intends to conduct the

study for ‘‘Infant Sleep Position and

SIDS Risk.’’ The CRMC is authorized by

Section 452 of Part G of Title IV of the

Public Health Service Act (42 U.S.C.

288) as amended by the NIH

Revitalization Act of 1993 (Pub. L. 103–

43).

The information proposed for

collection will be used by the NICHD to

study if there is any correlation between

the events occurring prior to death for

infants who died of SIDS or their

parents to determine the causes of SIDS.

The annual burden estimates are as

follows:

Case type

Est.

total

cases

Est. No.

of responses

Avg.

hours required for

total responses

SIDS .............. 600 480 1

Controls ......... 1200 960 1

Dated: January 19, 1996.

Benjamin E. Fulton,

Executive Officer, NICHD.

[FR Doc. 96–1448 Filed 1–26–96; 8:45 am]

BILLING CODE 4140–01–M

John E. Fogarty International Center

for Advanced Study in the Health

Sciences; Notice of Meeting of the

Fogarty International Center Advisory

Board

Pursuant to Public Law 92–463, as

amended, notice is hereby given of the

thirty-second meeting of the Fogarty

International Center (FIC) Advisory

Board, February 6, 1996, in the Lawton

Chiles International House (Building 16)

at the National Institutes of Health.

The meeting will be open to the

public from 8:30 a.m. to 10:30 a.m. In

addition to a report by the Director, FIC,

the agenda will focus on the status of

FIC programs and plans.

In accordance with the provisions of

sections 552b(c)(4) and 552b(c)(6), Title

5, United States Code and section 10(d)

of Public Law 92–463, as amended, the

meeting will be closed to the public

from 11:00 a.m. to adjournment for the

review of applications for awards under

the Senior International Fellowship

Program and the International Research

Fellowship Program; and the Fogarty

International Research Collaboration

Awards and HIV, AIDS and Related

Illnesses Collaboration Awards.

Paula Cohen, Committee Management

Officer, Fogarty International Center,

National Institutes of Health, Building

31, Room B2C08, 31 CENTER DR MSC

2220, Bethesda, MD 20892–2220,

telephone: 301–496–1491, will provide

a summary of the meeting and a roster

of the committee members upon

request.

Irene Edwards, Executive Secretary,

Fogarty International Center Advisory

Board, Building 31, Room B2C08,

telephone: 301–496–1491, will provide

substantive program information.

Individuals who plan to attend and

need special assistance, such as sign

language interpretation or other
Federal Register / Vol. 61, No. 19 / Monday, January 29, 1996 / Notices 2837

reasonable accommodations, should

contact Ms. Cohen at least 2 weeks in

advance of the meeting.

This notice is being published less

than 15 days prior to the above meeting

due to the partial shutdown of the

Federal Government and the urgent

need to meet timing limitations imposed

by the review funding cycle.

(Catalog of Federal Domestic Assistance

Program No. 93.989, Senior International

Awards Program)

Dated: January 22, 1996.

Susan K. Feldman,

Committee Management Officer, NIH.

[FR Doc. 96–1447 Filed 1–26–96; 8:45 am]

BILLING CODE 4140–01–M

National Cancer Institute; Notice of

Meeting

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following meeting

of the National Cancer Institute National

Cancer Advisory Board (NCAB)

Activities and Agenda Subcommittee.

The Committee Management Office,

National Cancer Institute, National

Institutes of Health, Executive Plaza

North, Room 630E, 9000 Rockville Pike,

Bethesda, Maryland 20892 (301/496–

5708), will provide summaries of the

meeting and a roster of the

subcommittee members upon request.

Individuals who plan to attend the

open session and need special

assistance, such as sign language

interpretation or other reasonable

accommodations, should contact Ms.

Carole Frank, Committee Management

Specialist, at 301/496–5708 in advance

of the meeting. Attendance by the

public will be limited to space available.

Committee Name: NCAB Activities and

Agenda Subcommittee.

Date: January 30, 1996.

Place: National Cancer Institute, Via

telephone conference, 6130 Executive Blvd.

EPN, Conference Rm. 640, Rockville, MD

20852.

Open: 1 p.m. to 2:30 p.m.

Agenda: Discussion of future NCAB agenda

items and other topics of interest, future of

possible mini-symposia, periodic information

updates, and organization of NCAB meetings

and subcommittee meetings.

Closed: 2:30 p.m. to 4 p.m.

Agenda: Discussion of the participation of

individual employees in support of NCAB

activities.

Contact Person: Marvin R. Kalt, Ph.D.,

National Cancer Institute, 6130 Executive

Blvd., EPN, Conference Rm. 640, Rockville,

MD 20852, Telephone: 301–496–5147.

The meeting will be closed in

accordance with the provisions set forth

in Section 552b(c)(6), Title 5, U.S.C. The

discussions could reveal personal

information including consideration of

personnel qualifications and

performance, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

This notice is appearing less than 15

days before the scheduled meeting due

to the partial shutdown of the Federal

Government.

(Catalog of Federal Domestic Assistance

Program Numbers: 93.393, Cancer Cause and

Prevention Research; 93.394, Cancer

Detection and Diagnosis Research; 93.395,

Cancer Treatment Research; 93.396, Cancer

Biology Research; 93.397, Cancer Centers

Support; 93.398, Cancer Research Manpower;

93.399, Cancer Control.)

Dated: January 23, 1996.

Susan K. Feldman,

Committee Management Officer, NIH.

[FR Doc. 96–1642 Filed 1–26–96; 8:45 am]

BILLING CODE 4140–01–M

National Institute on Deafness and

Other Communication Disorders;

Notice of Closed Meeting

Pursuant to Section 10(d) of the

Federal Advisory Committee Act,

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting:

Name of Committee: Communication

Disorders Review Committee.

Date: February 22–23, 1996.

Time: 8 a.m.–5:30 p.m., February 22; 8

a.m.–adjournment, February 23.

Place: Doubletree Hotel, 1750 Rockville

Pike, Rockville, MD 20852.

Contact Person: Craig A. Jordan, Ph.D.,

Scientific Review Administrator, NIDCD/

DEA/SRB, EPS Room 400C, 6120 Executive

Boulevard, MSC 7180, Bethesda, MD 20892–

7180, 301–496–8683.

Purpose/Agenda: To review and evaluate

grant applications.

The meeting will be closed in

accordance with the provisions set forth

in secs. 552b(c)(4) and 552b(c)(6), title 5,

U.S.C. The applications and/or

proposals and the discussion could

reveal confidential trade secrets or

commercial property such as patentable

material and personal information

concerning individuals associated with

the applications and/or proposals, the

disclosure of which could constitute a

clearly unwarranted invasion of

personal privacy.

(Catalog of Federal Domestic Assistance

Program No. 93.173 Biological Research

Related to Deafness and Communication

Disorders)

Dated: January 22, 1996.

Susan K. Feldman,

Committee Management Officer, NIH.

[FR Doc. 96–1446 Filed 1–26–96; 8:45 am]

BILLING CODE 4140–01–M

National Institute of Mental Health;

Notice of Closed Meetings

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meetings of the National Institute of

Mental Health Initial Review Group:

Agenda/Purpose: To review and evaluate

grant applications.

Committee Name: Services Research

Review Committee.

Date: February 6–February 7, 1996.

Time: 8:30 a.m.

Place: Hyatt Regency Bethesda, One

Bethesda Metro Center, Bethesda, MD 20814.

Contact Person: Angela L. Redlingshafer,

Parklawn, Room 9C–18, 5600 Fishers Lane,

Rockville, MD 20857, Telephone: 301–443–

1367.

Committee Name: Mental Disorders of

Aging Review Committee.

Date: February 8–February 9, 1996.

Time: 9 a.m.

Place: Chevy Chase Holiday Inn, 5520

Wisconsin Avenue, Chevy Chase, MD 20815.

Contact Person: W. Gregory Zimmerman,

Parklawn, Room 9C–18, 5600 Fishers Lane,

Rockville, MD 20857, Telephone: 301–443–

1340.

Committee Name: Health Behavior and

Prevention Review Committee.

Date: February 12–February 13, 1996.

Time: 9 a.m.

Place: Embassy Suites Hotel, 4300 Military

Road, NW., Washington, DC 20015.

Contact Person: Monica F. Woodfork,

Parklawn Building, Room 9C–26, 5600

Fishers Lane, Rockville, MD 20857,

Telephone: 301–443–4843.

Committee Name: Treatment Assessment

Review Committee.

Date: February 15–February 16, 1996.

Time: 8:30 a.m.

Place: Hyatt Regency Bethesda, One

Bethesda Metro Center, Bethesda, MD 20814.

Contact Person: Phyllis L. Zusman,

Parklawn Building, Room 9C–18, 5600

Fishers Lane, Rockville, MD 20857,

Telephone: 301–443–1340.

The meetings will be closed in

accordance with the provisions set forth

in secs. 552b(c)(4) and 552b(c)(6), Title

5, U.S.C. Applications and/or proposals

and the discussions could reveal

confidential trade secrets or commercial

property such as patentable material

and personal information concerning

individuals associated with the

applications and/or proposals, the

disclosure of which would constitute a

clearly unwarranted invasion of

personal privacy.